Related references
Note: Only part of the references are listed.THP-1 cell line: An in vitro cell model for immune modulation approach
Wasaporn Chanput et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Approaches to Tuberculosis Mucosal Vaccine Development Using Nanoparticles and Microparticles: A Review
Liliana Aranha Caetano et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Factorial design analysis and optimisation of alginate-Ca-chitosan microspheres
Liljana Makraduli et al.
JOURNAL OF MICROENCAPSULATION (2013)
Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles
A. Cadete et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice
Suzanne M. Bal et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model
Miguel A. Rodrigues et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations
Martti Kaasalainen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics
Mohsen Tafaghodi et al.
VACCINE (2012)
Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems
L. Figueiredo et al.
VACCINE (2012)
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers
Pegi Ahlin Grabnar et al.
JOURNAL OF MICROENCAPSULATION (2011)
Development and characterization of chitosan coated poly-(ε-caprolactone) nanoparticulate system for effective immunization against influenza
Nand Kishore Gupta et al.
VACCINE (2011)
Evaluation of Mucoadhesive PLGA Microparticles for Nasal Immunization
Dilip Pawar et al.
AAPS JOURNAL (2010)
Evaluation of Chitosan/Alginate Beads Using Experimental Design: Formulation and In Vitro Characterization
Sevgi Takka et al.
AAPS PHARMSCITECH (2010)
Chitosan-based delivery systems for protein therapeutics and antigens
Maryam Amidi et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
Chunbai He et al.
BIOMATERIALS (2010)
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
Stefan H. E. Kaufmann
IMMUNITY (2010)
Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination
Bram Slutter et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nanosystem drug targeting: Facing up to complex realities
Pakatip Ruenraroengsak et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems
Deepa Mohanan et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nanobead-based interventions for the treatment and prevention of tuberculosis
Gareth Griffiths et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Cell-Mediated Immune Responses in Tuberculosis
Andrea M. Cooper
ANNUAL REVIEW OF IMMUNOLOGY (2009)
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ε-caprolactone-based nanoparticles
H. F. Florindo et al.
BIOMATERIALS (2009)
Application of chitosan microspheres for nasal delivery of vaccines
Mi Lan Kang et al.
BIOTECHNOLOGY ADVANCES (2009)
A Review of the Antimicrobial Activity of Chitosan
Rejane C. Goy et al.
POLIMEROS-CIENCIA E TECNOLOGIA (2009)
Chitosan and its antimicrobial potential - a critical literature survey
Dina Raafat et al.
MICROBIAL BIOTECHNOLOGY (2009)
Improving vaccine delivery using novel adjuvant systems
Michael E. Pichichero
HUMAN VACCINES (2008)
Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung
Ruchi Jain et al.
PLOS ONE (2008)
On the killing of mycobacteria by macrophages
Luisa Jordao et al.
CELLULAR MICROBIOLOGY (2008)
Alginate/Chitosan nanoparticles are effective for oral insulin delivery
B. Sarmento et al.
PHARMACEUTICAL RESEARCH (2007)
Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation
B. Sarmento et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2007)
Host innate immune response to Mycobacterium tuberculosis
Kamlesh Bhatt et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB/c mice
Soheila Ajdary et al.
VACCINE (2007)
Synergistic effect of bacillus Calmette Guerin and a tuberculosis subunit vaccine in cationic liposomes: Increased immunogenicity and protection
Jes Dietrich et al.
JOURNAL OF IMMUNOLOGY (2007)
N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model
Maryam Amidi et al.
VACCINE (2007)
Stabilizing effects of calcium alginate microspheres on mycobacterium bovis BCG intended for oral vaccination
F. Dobakhti et al.
JOURNAL OF MICROENCAPSULATION (2006)
Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies
Bruno Sarmento et al.
CARBOHYDRATE POLYMERS (2006)
Essay - Envisioning future strategies for vaccination against tuberculosis
Stefan H. E. Kaufmann
NATURE REVIEWS IMMUNOLOGY (2006)
Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN
Mohsen Tafaghodi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Particulate delivery systems for vaccines: what can we expect?
Vincent W. Bramwell et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Effect of MW and concentration of chitosan on antibacterial activity of Escherichia coli
Nan Liu et al.
CARBOHYDRATE POLYMERS (2006)
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
J Kazzaz et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity
Martha Kalkanidis et al.
METHODS (2006)
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
C Foged et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
HO Alpar et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Immunity in response to particulate antigen-delivery systems
T Storni et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier
KL Douglas et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2005)
A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery
SC Chen et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan
EA McNeela et al.
VACCINE (2004)
Activated THP-1 cells:: An attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates
SA Theus et al.
INFECTION AND IMMUNITY (2004)
Chitosan: antimicrobial activity, interactions with food components and applicability as a coating on fruit and vegetables
F Devlieghere et al.
FOOD MICROBIOLOGY (2004)
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
A Vila et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines
BC Baudner et al.
VACCINE (2003)
Phagocytosis: latex leads the way
M Desjardins et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres
SJ De et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Polyelectrolye complex formation between alginate and chitosan as a function of pH
FA Simsek-Ege et al.
JOURNAL OF APPLIED POLYMER SCIENCE (2003)
Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice
IM van der Lubben et al.
VACCINE (2003)
Thermogravimetric and FTIR studies of chitosan blends
A Pawlak et al.
THERMOCHIMICA ACTA (2003)
Study on antimicrobial activity of chitosan with different molecular weights
LY Zheng et al.
CARBOHYDRATE POLYMERS (2003)
The efficacy of the heat killing of Mycobacterium tuberculosis
C Doig et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Recent advances in vaccine adjuvants
M Singh et al.
PHARMACEUTICAL RESEARCH (2002)
Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination
MOC Ota et al.
JOURNAL OF IMMUNOLOGY (2002)
Alginate in drug delivery systems
HH Tonnesen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
Chitosan and its derivatives in mucosal drug and vaccine delivery
IM van der Lubben et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Microparticles for intranasal immunization
M Vajdy et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L Thiele et al.
JOURNAL OF CONTROLLED RELEASE (2001)